filmov
tv
Improving male breast cancer treatment
Показать описание
Liquid Biopsy Literacy:
This is the only distinguished medical oncology research page that will teach you about SFRP4 liquid biopsy clinical trials better than universities and hospitals.
We have solutions to improve treatments. Here's something new and promising! With the potential of Medonctherapeutics' stem CTC technology and the initiation of Wnt antagonist: secreted frizzled-related protein 4 (SFRP4) treatment, we're looking at a hopeful future for cancer diagnosis. We're proud to be the distinguished pioneer in leading the SFRP4 liquid biopsy products in Perth, Western Australia, with an academic research patent portfolio track record for commercial projects.
Contact us and book now at
The CTC lines, circulating cancer stem cell spheres, and organoids hold promise for future tailored SFRP4 and Wnt antagonist treatments.
Medical oncology research content writing, video recording and editing by Dr. Vanathi Perumal
Check out my other helpful breast cancer CTC links:
Disclaimer
It is unrelated to Curtin University-Sir Charles Gairdner Hospital's radiation oncology research products.
This podcast is intended only for educational and informational purposes, not as medical advice/device. We offer on-call medical oncology scientists services for liquid biopsy products through our website and Zoom/phone call meetings. Book for professional research consultations/meetings and grant proposals, manuscript writing, medical writing, clinical trial study protocols, and rebuttals at an hourly rate of 85A$. The business is in an initial phase; no refund policy applies. They are offered under CDA or NDA. Administrative charges apply for using the medonctherapeutics method and testing Australian IP CTC research liquid biopsy portfolio online services. Charges apply for testing unpublished all-in-one capability stem CTC and spheres technology on clinical samples.
References:
Transl Cancer Res. 2020 Jul; 9(7): 4297–4305.
Science. 2014 Jul 11;345(6193):216-20.
Cell. 2014 Aug 28;158(5):1110-1122.
Follow us on social media:
This is the only distinguished medical oncology research page that will teach you about SFRP4 liquid biopsy clinical trials better than universities and hospitals.
We have solutions to improve treatments. Here's something new and promising! With the potential of Medonctherapeutics' stem CTC technology and the initiation of Wnt antagonist: secreted frizzled-related protein 4 (SFRP4) treatment, we're looking at a hopeful future for cancer diagnosis. We're proud to be the distinguished pioneer in leading the SFRP4 liquid biopsy products in Perth, Western Australia, with an academic research patent portfolio track record for commercial projects.
Contact us and book now at
The CTC lines, circulating cancer stem cell spheres, and organoids hold promise for future tailored SFRP4 and Wnt antagonist treatments.
Medical oncology research content writing, video recording and editing by Dr. Vanathi Perumal
Check out my other helpful breast cancer CTC links:
Disclaimer
It is unrelated to Curtin University-Sir Charles Gairdner Hospital's radiation oncology research products.
This podcast is intended only for educational and informational purposes, not as medical advice/device. We offer on-call medical oncology scientists services for liquid biopsy products through our website and Zoom/phone call meetings. Book for professional research consultations/meetings and grant proposals, manuscript writing, medical writing, clinical trial study protocols, and rebuttals at an hourly rate of 85A$. The business is in an initial phase; no refund policy applies. They are offered under CDA or NDA. Administrative charges apply for using the medonctherapeutics method and testing Australian IP CTC research liquid biopsy portfolio online services. Charges apply for testing unpublished all-in-one capability stem CTC and spheres technology on clinical samples.
References:
Transl Cancer Res. 2020 Jul; 9(7): 4297–4305.
Science. 2014 Jul 11;345(6193):216-20.
Cell. 2014 Aug 28;158(5):1110-1122.
Follow us on social media:
0:04:26
0:04:39
0:07:28
0:02:00
0:03:01
0:01:01
0:00:46
0:07:17
0:04:44
0:00:43
0:04:43
0:01:54
0:01:32
0:01:53
0:01:48
0:08:47
0:00:37
0:00:52
0:05:56
0:00:39
0:09:00
0:05:36
0:02:20
0:07:11